Cold & Flu
Cold & Flu, licence 80097131: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Immune Boost, Immunity Support
- Licence holder
- Ovensa Inc.
- NPN or DIN-HM
- 80097131
- Status
- Active licence
- Licence date
- 15 February 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly-bêta-(1,4)-2-amino-2-désoxy-d-glucose Source : Chitosane | 100.0 mg | Not calculated |
| Cannabis sativa Source : Graine(s) | 100.0 mg | Not calculated |
| Echinacea purpurea Source : Racine | 600.0 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Echinacea is traditionally used in Herbal Medicine to help relieve cold symptoms. Used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract. Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are taking blood thinners. Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner /health care provider/health care professional/doctor/physician prior to use if you are taking medications to suppress the immune system (immunosuppressive medications).
- Effets indésirables connus
May cause abdominal pain, bloating, constipation, indigestion and/or diarrhea.
Source
Official Health Canada record, licence 80097131
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.